Cue Biopharma, Inc. Form 8-K Summary
Business Context and Reporting Period
This Form 8-K reports the certified results of the 2018 Annual Meeting of Stockholders held by Cue Biopharma, Inc. on June 12, 2018. The company is incorporated in Delaware and is designated as an emerging growth company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
The following matters were submitted to a vote of security holders:
- Proposal 1: Election of Directors
- Seven directors were nominated by the Board of Directors. All seven nominees received a majority of votes cast "For" and were elected.
- Vote Breakdown:
- Daniel R. Passeri: 4,139,495 For; 1,476,460 Withheld
- Peter A. Kiener: 4,133,082 For; 1,482,873 Withheld
- Anthony DiGiandomenico: 4,137,386 For; 1,478,569 Withheld
- Cameron Gray: 4,136,926 For; 1,479,029 Withheld
- Christopher Marlett: 4,136,926 For; 1,479,029 Withheld
- Steven McKnight: 3,732,979 For; 1,882,976 Withheld
- Barry Simon: 3,967,727 For; 1,648,228 Withheld
- Broker Non-Votes totaled 7,787,476 for all director nominees.
- Proposal 2: Ratification of Independent Auditor
- Stockholders ratified the appointment of Gumbiner Savett Inc. as the independent registered public accounting firm for 2018.
- Vote Breakdown: 12,160,388 For; 18,050 Against; 1,224,993 Abstain; 0 Broker Non-Votes.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Verify the full composition of the Board of Directors following the election of the seven nominees.
- Confirm the engagement terms and scope of work with the newly ratified auditor, Gumbiner Savett Inc.
- Review the definitive proxy statement referenced in the filing for detailed background on the director nominees and the audit committee's rationale for the auditor selection.